Treatment with calcitriol in patients with renal impairment is associated with a significant reduction in COVID-19 death.
The results are the result of a population study carried out in Catalonia by the Parc Taulí Health Corporation, the University of Barcelona (UB), the Hospital del Mar Institute for Medical Research (IMIM) and the Health Quality and Evaluation Agency of Catalonia (AQuAS). read more